
Rei Tsang Shiao
Examiner (ID: 13461)
| Most Active Art Unit | 1628 |
| Art Unit(s) | 1626, 1628, 1629, 1691 |
| Total Applications | 3000 |
| Issued Applications | 2172 |
| Pending Applications | 215 |
| Abandoned Applications | 676 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 303373
[patent_doc_number] => 07534509
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-05-19
[patent_title] => 'Ambient-temperature molten salts and process for producing the same'
[patent_app_type] => utility
[patent_app_number] => 10/979220
[patent_app_country] => US
[patent_app_date] => 2004-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12528
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/534/07534509.pdf
[firstpage_image] =>[orig_patent_app_number] => 10979220
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/979220 | Ambient-temperature molten salts and process for producing the same | Nov 2, 2004 | Issued |
Array
(
[id] => 7105526
[patent_doc_number] => 20050107447
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-19
[patent_title] => 'Novel lysophosphatidic acid receptor agonists and antagonists'
[patent_app_type] => utility
[patent_app_number] => 10/980565
[patent_app_country] => US
[patent_app_date] => 2004-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 16141
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0107/20050107447.pdf
[firstpage_image] =>[orig_patent_app_number] => 10980565
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/980565 | Novel lysophosphatidic acid receptor agonists and antagonists | Nov 2, 2004 | Abandoned |
Array
(
[id] => 501135
[patent_doc_number] => 07205312
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-04-17
[patent_title] => 'N-[4-(heteroarylmethyl)phenyl]-heteroarylamines'
[patent_app_type] => utility
[patent_app_number] => 10/979362
[patent_app_country] => US
[patent_app_date] => 2004-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16776
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/205/07205312.pdf
[firstpage_image] =>[orig_patent_app_number] => 10979362
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/979362 | N-[4-(heteroarylmethyl)phenyl]-heteroarylamines | Nov 1, 2004 | Issued |
Array
(
[id] => 5771620
[patent_doc_number] => 20050267071
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-01
[patent_title] => 'Inhibitors of coronavirus protease and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/979871
[patent_app_country] => US
[patent_app_date] => 2004-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 73916
[patent_no_of_claims] => 79
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0267/20050267071.pdf
[firstpage_image] =>[orig_patent_app_number] => 10979871
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/979871 | Inhibitors of coronavirus protease and methods of use thereof | Oct 31, 2004 | Abandoned |
Array
(
[id] => 6940030
[patent_doc_number] => 20050113593
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Preparation of an alkenylphosphonic acid derivative'
[patent_app_type] => utility
[patent_app_number] => 10/977436
[patent_app_country] => US
[patent_app_date] => 2004-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5544
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20050113593.pdf
[firstpage_image] =>[orig_patent_app_number] => 10977436
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/977436 | Preparation of an alkenylphosphonic acid derivative | Oct 31, 2004 | Issued |
Array
(
[id] => 5051910
[patent_doc_number] => 20070032455
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-08
[patent_title] => 'Novel nitrophenyl mustard and nitrophenylaziridine alcohols and their corresponding phosphates and their use as targeted cytotoxic agents'
[patent_app_type] => utility
[patent_app_number] => 10/577078
[patent_app_country] => US
[patent_app_date] => 2004-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21890
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20070032455.pdf
[firstpage_image] =>[orig_patent_app_number] => 10577078
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/577078 | Nitrophenyl mustard and nitrophenylaziridine alcohols and their corresponding phosphates and their use as targeted cytotoxic agents | Oct 28, 2004 | Issued |
Array
(
[id] => 318865
[patent_doc_number] => 07521575
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-04-21
[patent_title] => 'Sterically hindered chelate phosphinite-phosphite ligand, catalyst, comprising at least one nickel(0) complex stabilized by said ligand and method for production of nitriles'
[patent_app_type] => utility
[patent_app_number] => 10/577138
[patent_app_country] => US
[patent_app_date] => 2004-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6587
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/521/07521575.pdf
[firstpage_image] =>[orig_patent_app_number] => 10577138
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/577138 | Sterically hindered chelate phosphinite-phosphite ligand, catalyst, comprising at least one nickel(0) complex stabilized by said ligand and method for production of nitriles | Oct 27, 2004 | Issued |
Array
(
[id] => 4984709
[patent_doc_number] => 20070151046
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-05
[patent_title] => 'Neutral and cationic naphthalene and colorants for keratin fibers containing these compounds'
[patent_app_type] => utility
[patent_app_number] => 10/585031
[patent_app_country] => US
[patent_app_date] => 2004-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6788
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0151/20070151046.pdf
[firstpage_image] =>[orig_patent_app_number] => 10585031
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/585031 | Neutral and cationic naphthalene and colorants for keratin fibers containing these compounds | Oct 25, 2004 | Issued |
Array
(
[id] => 5236358
[patent_doc_number] => 20070128515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-07
[patent_title] => 'Process for the preparation of organic salts containing bis(perfluoroalkyl) phosphinate anions'
[patent_app_type] => utility
[patent_app_number] => 10/579555
[patent_app_country] => US
[patent_app_date] => 2004-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7906
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20070128515.pdf
[firstpage_image] =>[orig_patent_app_number] => 10579555
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/579555 | Process for the preparation of organic salts containing bis(perfluoroalkyl) phosphinate anions | Oct 25, 2004 | Issued |
Array
(
[id] => 469401
[patent_doc_number] => 07232921
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-06-19
[patent_title] => 'Method for preparing a biphenylphosphonate compound'
[patent_app_type] => utility
[patent_app_number] => 10/972396
[patent_app_country] => US
[patent_app_date] => 2004-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2214
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/232/07232921.pdf
[firstpage_image] =>[orig_patent_app_number] => 10972396
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/972396 | Method for preparing a biphenylphosphonate compound | Oct 25, 2004 | Issued |
Array
(
[id] => 4983617
[patent_doc_number] => 20070088176
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-19
[patent_title] => 'Process for the preparation of mono-and bis(fluoroalkyl)phosphoranes and the corresponding acids and phosphates'
[patent_app_type] => utility
[patent_app_number] => 10/579556
[patent_app_country] => US
[patent_app_date] => 2004-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4865
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0088/20070088176.pdf
[firstpage_image] =>[orig_patent_app_number] => 10579556
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/579556 | Process for the preparation of mono- and bis(fluoroalkyl)phosphoranes and the corresponding acids and phosphates | Oct 21, 2004 | Issued |
Array
(
[id] => 925830
[patent_doc_number] => 07317128
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-01-08
[patent_title] => 'Process for preparing TCD-diamine'
[patent_app_type] => utility
[patent_app_number] => 10/967597
[patent_app_country] => US
[patent_app_date] => 2004-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5809
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/317/07317128.pdf
[firstpage_image] =>[orig_patent_app_number] => 10967597
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/967597 | Process for preparing TCD-diamine | Oct 17, 2004 | Issued |
Array
(
[id] => 352702
[patent_doc_number] => 07491724
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-02-17
[patent_title] => 'Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases'
[patent_app_type] => utility
[patent_app_number] => 10/965215
[patent_app_country] => US
[patent_app_date] => 2004-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 86736
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/491/07491724.pdf
[firstpage_image] =>[orig_patent_app_number] => 10965215
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/965215 | Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases | Oct 14, 2004 | Issued |
Array
(
[id] => 6939780
[patent_doc_number] => 20050113343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Solid-state form of alendronate sodium and preparation thereof'
[patent_app_type] => utility
[patent_app_number] => 10/964406
[patent_app_country] => US
[patent_app_date] => 2004-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5080
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20050113343.pdf
[firstpage_image] =>[orig_patent_app_number] => 10964406
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/964406 | Solid-state form of alendronate sodium and preparation thereof | Oct 12, 2004 | Abandoned |
Array
(
[id] => 373398
[patent_doc_number] => 07473701
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-01-06
[patent_title] => 'Substituted indazoles, compositions containing them, method of production and use'
[patent_app_type] => utility
[patent_app_number] => 10/963880
[patent_app_country] => US
[patent_app_date] => 2004-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57893
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/473/07473701.pdf
[firstpage_image] =>[orig_patent_app_number] => 10963880
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/963880 | Substituted indazoles, compositions containing them, method of production and use | Oct 12, 2004 | Issued |
Array
(
[id] => 7020135
[patent_doc_number] => 20050222154
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-06
[patent_title] => 'Multiply-substituted tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents'
[patent_app_type] => utility
[patent_app_number] => 10/961375
[patent_app_country] => US
[patent_app_date] => 2004-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29414
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0222/20050222154.pdf
[firstpage_image] =>[orig_patent_app_number] => 10961375
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/961375 | Multiply-substituted tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents | Oct 11, 2004 | Abandoned |
Array
(
[id] => 5247842
[patent_doc_number] => 20070244076
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-18
[patent_title] => 'Site and Rate Selective Prodrug Formulations of D609 with Antioxidant and Anticancer Activity'
[patent_app_type] => utility
[patent_app_number] => 10/575188
[patent_app_country] => US
[patent_app_date] => 2004-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 26452
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0244/20070244076.pdf
[firstpage_image] =>[orig_patent_app_number] => 10575188
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/575188 | Site and Rate Selective Prodrug Formulations of D609 with Antioxidant and Anticancer Activity | Oct 7, 2004 | Abandoned |
Array
(
[id] => 5924615
[patent_doc_number] => 20060241167
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-26
[patent_title] => 'Crystalline form of fluvastatin sodium'
[patent_app_type] => utility
[patent_app_number] => 10/576784
[patent_app_country] => US
[patent_app_date] => 2004-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 1427
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20060241167.pdf
[firstpage_image] =>[orig_patent_app_number] => 10576784
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/576784 | Crystalline form of Fluvastatin sodium | Oct 5, 2004 | Issued |
Array
(
[id] => 7207905
[patent_doc_number] => 20050043403
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-24
[patent_title] => 'N-unsubstituted amidinium salts'
[patent_app_type] => utility
[patent_app_number] => 10/958870
[patent_app_country] => US
[patent_app_date] => 2004-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2626
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0043/20050043403.pdf
[firstpage_image] =>[orig_patent_app_number] => 10958870
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/958870 | N-unsubstituted amidinium salts | Oct 4, 2004 | Abandoned |
Array
(
[id] => 925810
[patent_doc_number] => 07317108
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-01-08
[patent_title] => 'Boron complexation strategy for use in manipulating 1-acyldipyrromethanes'
[patent_app_type] => utility
[patent_app_number] => 10/956781
[patent_app_country] => US
[patent_app_date] => 2004-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 24645
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/317/07317108.pdf
[firstpage_image] =>[orig_patent_app_number] => 10956781
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/956781 | Boron complexation strategy for use in manipulating 1-acyldipyrromethanes | Sep 30, 2004 | Issued |